News articles about Vascular Solutions (NASDAQ:VASC) have trended somewhat positive recently, according to Accern Sentiment. Accern rates the sentiment of press coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Vascular Solutions earned a news impact score of 0.13 on Accern’s scale. Accern also gave news stories about the medical device company an impact score of 44.6518933887047 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

TRADEMARK VIOLATION NOTICE: This report was originally reported by Daily Political and is owned by of Daily Political. If you are accessing this report on another site, it was stolen and republished in violation of U.S. and international copyright and trademark legislation. The original version of this report can be accessed at https://www.dailypolitical.com/2017/11/08/somewhat-positive-press-coverage-somewhat-unlikely-to-affect-vascular-solutions-vasc-share-price.html.

About Vascular Solutions

Vascular Solutions, Inc is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company’s product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world.

Insider Buying and Selling by Quarter for Vascular Solutions (NASDAQ:VASC)

Receive News & Ratings for Vascular Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vascular Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.